Poultry Vaccines Market Report By Insights, Size, and Growth

The poultry vaccines market is anticipated to expand from US$ 8.39 billion in 2023 to US$ 12.90 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.7% from 2021 to 2031.

The increasing incidence of poultry diseases, along with innovations in vectored and combination vaccines, are significant drivers of growth in the poultry vaccines sector. However, challenges such as product recalls can hinder market expansion. Moreover, the ongoing advancements in vectored and combination vaccines are expected to be prominent trends in the poultry vaccines market throughout the period from 2021 to 2031.

Growth Drivers:

Increasing Incidence of Poultry Diseases Fuels Market Expansion

Poultry farming is crucial for producing various animal proteins, including eggs and meat. As poultry production rises, the risk of exposure to numerous zoonotic diseases, such as "Fowl disease," increases, leading to significant economic repercussions, especially in developing nations. Chickens, in particular, are susceptible to a range of infections, including bacterial, viral, parasitic, and fungal diseases. Viral outbreaks can lead to severe conditions such as Newcastle disease, avian influenza, and infectious bursal disease, affecting a wide array of poultry species.

The following table illustrates the outbreaks of avian influenza among mammals in various countries during 2022:

Country	Poultry Diseases	Disease Outbreak (2022)
Argentina	H5	18
Chile		34
Norway		2
Uruguay		3
Peru		12
Brazil	H5N1	5
Canada		40
China		1
Estonia		1
Finland		76
France		2
Ireland		2
Italy		3
Japan		4
Russia		1
Canada	H5N5	2
Denmark	H5N8	1

Source: World Organization for Animal Health 2023

Poultry diseases significantly contribute to chick mortality and reduced livestock productivity. Farmers globally are incurring substantial economic losses due to the spread of zoonotic diseases, which pose serious health risks to mammals. For instance, poultry coccidiosis is a prevalent disease worldwide, leading to considerable losses from mortality, decreased body weight, and additional costs for preventive and therapeutic measures. According to DSM, farmers lose approximately US$ 3 billion annually due to coccidiosis in chickens and other avian species. Newcastle disease is another costly ailment, causing significant production losses for farmers in developing countries that export poultry products. A report from the International Journal of Current Microbiology and Applied Sciences (IJCMAS) published in October 2021 indicated that losses from Newcastle disease mortality and expenses on live birds across 25 commercial broiler farms ranged from INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. The income from selling live birds per farm varied from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infections.

Thus, the increasing prevalence of poultry diseases, which leads to significant economic losses, is driving the demand for poultry vaccinations and consequently propelling market growth.

Report Segmentation and Scope:

The poultry vaccines market is categorized based on type, technology, dosage form, disease, route of administration, and end user. The market is divided into broiler and layer segments, with the broiler segment holding a larger share in 2023.

By technology, the market includes live attenuated vaccines, inactivated vaccines, and recombinant vaccines, with live attenuated vaccines dominating the market share in 2023.

In terms of dosage form, the market is classified into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines, where liquid vaccines led the market in 2023.

Regarding diseases, the market encompasses avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others, with avian influenza being the leading segment in 2023.

The route of administration includes drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others, with the drinking water segment being the most prominent in 2023.

Finally, the end user segment consists of poultry farms, veterinary hospitals, and poultry vaccination centers & clinics, with poultry farms dominating the market in 2023.

Type-Based Insights

The poultry vaccines market is divided into broiler and layer types. The broiler segment accounted for the largest market share in 2023. Broilers are young chickens, typically six to eight weeks old, weighing between 1.5-2.0 kg, and are primarily raised for meat production. Most commercial broilers reach slaughter weight between four and seven weeks of age. Due to selective breeding for rapid growth, broiler breeds are particularly susceptible to skeletal deformities, skin and eye diseases, and heart disorders. To maintain flock health, factors such as ventilation, housing, stocking density, and in-house operations are regularly monitored. Male broilers, which grow faster than females, require more space and nutrients, leading to separate rearing practices in many regions.

Vaccination programs are critical for preventing diseases, especially in broiler farming. Vaccines contain either attenuated pathogens or low concentrations that induce mild infections or antigenic components, thereby immunizing broilers against specific diseases. For instance, Marek's disease vaccines are administered at hatcheries on the first day of a broiler's life via subcutaneous injection. Consequently, the broiler segment is expected to significantly contribute to the growth of the poultry vaccines market during the forecast period.

Regional Analysis:

The geographical analysis of the poultry vaccines market is segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. This report provides a comprehensive overview of global and regional market trends, key players, regulations, and recent developments.

The Asia Pacific region has emerged as the leader in the poultry vaccines market and is projected to experience the highest CAGR in the coming years. Within this region, China holds the largest share of the poultry vaccines market as of 2023. The rapid economic growth and urbanization in China, coupled with its robust healthcare system, contribute to this market expansion. The growth is driven by the increasing demand for poultry meat, rising consumption of animal-derived food products, a growing livestock population, heightened awareness of animal health, and a surge in poultry disease outbreaks. Favorable government initiatives promoting vaccination in China are also pivotal in driving the growth of the poultry vaccines market.

Poultry Vaccines Market Report By Insights, Size, and Growth - 2031

Growth Drivers:

Increasing Incidence of Poultry Diseases Fuels Market Expansion

Report Segmentation and Scope:

Type-Based Insights

Regional Analysis:

TABLE OF CONTENTS

LIST OF TABLES

LIST OF FIGURES

Related Reports